BIOEX Stock Overview
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Bioextrax AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr2.47 |
52 Week High | kr7.95 |
52 Week Low | kr1.54 |
Beta | 2.72 |
1 Month Change | 23.50% |
3 Month Change | 10.02% |
1 Year Change | -63.30% |
3 Year Change | -88.90% |
5 Year Change | n/a |
Change since IPO | -38.25% |
Recent News & Updates
Recent updates
Shareholder Returns
BIOEX | SE Machinery | SE Market | |
---|---|---|---|
7D | 10.3% | 3.1% | 1.4% |
1Y | -63.3% | 22.3% | 8.6% |
Return vs Industry: BIOEX underperformed the Swedish Machinery industry which returned 19.9% over the past year.
Return vs Market: BIOEX underperformed the Swedish Market which returned 4.4% over the past year.
Price Volatility
BIOEX volatility | |
---|---|
BIOEX Average Weekly Movement | 17.7% |
Machinery Industry Average Movement | 4.7% |
Market Average Movement | 6.1% |
10% most volatile stocks in SE Market | 13.3% |
10% least volatile stocks in SE Market | 3.6% |
Stable Share Price: BIOEX's share price has been volatile over the past 3 months.
Volatility Over Time: BIOEX's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | 13 | Edvard Hall | www.bioextrax.com |
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. It harvests bioplastics (PHA) granules, organic hydrolyzed protein, keratin fibers, bio-oils, protein-rich by products, and amino acids from bacteria. The company was incorporated in 2014 and is based in Lund, Sweden.
Bioextrax AB (publ) Fundamentals Summary
BIOEX fundamental statistics | |
---|---|
Market cap | kr72.21m |
Earnings (TTM) | -kr21.51m |
Revenue (TTM) | kr3.01m |
24.0x
P/S Ratio-3.4x
P/E RatioIs BIOEX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BIOEX income statement (TTM) | |
---|---|
Revenue | kr3.01m |
Cost of Revenue | kr1.34m |
Gross Profit | kr1.67m |
Other Expenses | kr23.18m |
Earnings | -kr21.51m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.74 |
Gross Margin | 55.53% |
Net Profit Margin | -714.76% |
Debt/Equity Ratio | 0% |
How did BIOEX perform over the long term?
See historical performance and comparison